Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Monday, August 14, 2017 (2:30–4:00pm)
Concurrent Breakout Sessions #1

Prevention/Research

Dollars and Sense: Program, Patient, and Clinical Perspectives About Costs of Colorectal Cancer Along the Cancer Continuum

Session Moderator: Juan Rodriguez, MPH, MS, CDC

Of cancers that affect both men and women, colorectal cancer is the second leading cause of cancer death in the United States. Screening helps find colorectal cancer at an early stage, when treatment often leads to a cure. This session addresses the costs of colorectal cancer screening and treatment from three unique perspectives.

  1. Costs of Promoting Cancer Screening: Evidence from CDC’s Colorectal Cancer Control Program (CRCCP)
    Florence Tangka, PhD, CDC; Sujha Subramanian, PhD, RTI International; Sonja Hoover, MPP, RTI International; Janet Royalty, MS, CDC; Kristy Joseph, MA, CDC; Amy DeGroff, PhD, CDC; Djenaba Joseph, PhD, CDC; Sajal Chattopadhyay, PhD, CDC
  2. Costs of Colorectal Cancer Screening Provision in CDC’s Colorectal Cancer Control Program: Comparisons of Colonoscopy and FOBT/FIT-Based Screening
    Sujha Subramanian, PhD, RTI International; Florence Tangka, PhD, CDC; Sonja Hoover, MPP, RTI International; Janet Royalty, MS, CDC; Amy DeGroff, PhD, CDC; Djenaba Joseph, PhD, CDC
  3. Costs for Colonoscopy-Based Colorectal Cancer Screening: Experience of Low-income Individuals Undergoing Free Colonoscopies
    Sonja Hoover, MPP, RTI International; Sujha Subramanian, PhD, RTI International; Florence Tangka, PhD, CDC; Maggie Cole-Beebe, PhD, RTI International; Amy Sun, AB, RTI International; Cheryl Kramer, MBA, Philadelphia Department of Public Health; Gina Pacillio, BSN, Philadelphia Department of Public Health
  4. Comparison of Colon and Rectal Cancer Treatment Cost by Stage at Diagnosis for Medicare Beneficiaries
    Sujha Subramanian, Florence Tangka, PhD, CDC; Sonja Hoover, MPP, RTI International; Lisa Lines, PhD, RTI International; Robert Baker, BA, RTI International; Marion Nadel, PhD, CDC; Susan Sabatino, MD, CDC; Sarah Manson, BS, CTR, CDC; Frances Babcock, BS, MT, CTR; Lisa C. Richardson, MD, MPH, CDC

 Top of Page

Communication/Programmatic

Evolution of Comprehensive Cancer Control Plans and Partnerships

Session Moderator: Leslie Given, MPA, Strategic Health Concepts

The development of comprehensive cancer control (CCC) plans and partnerships began in 1998. Now, CCC plans and their implementation are more streamlined and strategic and CCC partnerships are more focused. This session will provide a historical context for the evolution of CCC in the United States, give examples of how CCC plans and partnerships have changed over time, and describe key factors of success for CCC partnerships.

  1. Evolution of Comprehensive Cancer Control Plans and Partnerships: Historical Context
    Karin Hohman, RN, MBA, Strategic Health Concepts
  2. Evolution of Comprehensive Cancer Control Plans and Partnerships: Impact and Key Success Factors
    Leslie Given, BA, MPA, Strategic Health Concepts
  3. Evolution of Comprehensive Cancer Control Plans and Partnerships: Kansas’ Perspective
    Julie F. Sergeant, PhD, Kansas Department of Health and Environment
  4. Evolution of Comprehensive Cancer Control Plans and Partnerships: Setting Priorities and Focusing Implementation Efforts
    Dilhara Muthukuda, Michigan Department of Health and Human Services; Polly Hager, Michigan Department of Community Health

 Top of Page

Communication/Research

Undue Burden: Understanding and Mitigating Cancer Survivors’ Increased Risks

Session Moderator: Nina Miller, American College of Surgeons Commission on Cancer

Cancer diagnosis and treatment can result in physical, psychosocial, and financial challenges for survivors. This panel will highlight survey data that describe distinct challenges cancer survivors face—including increased risk for depression, financial distress, and hospitalization and offer recommendations for mitigating these risks.

  1. Financial Impact of Cancer Care on Survivors: Results from the 2015 LIVESTRONG Survey
    Aditi Narayan, MS, LIVESTRONG Foundation; Loyce Pace, MPH, LIVESTRONG Foundation; Carla Bann, RTI International; Katherine Treiman, PhD, MPH, RTI International; Linda Squiers, RTI International
  2. Adult Cancer Survivors Receiving Flu Vaccination: The Importance of Follow-Up Care Instructions
    S. Cristina Oancea, PhD, MS, MSc, University of North Dakota; Vinay K. Cheruvu, PhD, MS, MSc, PGD-MISCA, Kent State University
  3. Examining the Mutual Benefits of a Peer Support Program to Facilitate Adaptation Among Women Affected by Breast/Ovarian Cancer: The Sharsheret Experience
    Adina Fleischmann, Sharsheret; Elana Silber, Sharsheret; Kathryn Rehberg, Georgetown Lombardi Comprehensive Cancer Center; Suzanne O’Neill, Georgetown Lombardi Comprehensive Cancer Center; Kenneth Tercyak, Georgetown Lombardi Comprehensive Cancer Center

 Top of Page

Communication/Programmatic

Let’s Dance: Programmatic and Public Partnerships to Improve Cancer Prevention and Control

Session Moderator: Shayne Galloway, PhD, MPH, CDC

Partnerships are foundational to public health programs, including cancer prevention and control ones. This session will explore how organizations have worked together to address needs in their communities.

  1. Cancer Survivorship Needs Through the Lens of the National Comprehensive Cancer Control Program
    Julie Townsend, MS, CDC; John M. Rose, PhD, Battelle Memorial Institute; Annette Gardner, BA, GISP, CDC; Adrienne Cocci, MPH, Battelle Memorial Institute
  2. Innovative Public-Private Partnerships to Address Lung Cancer Disparities
    Dwana “Dee” Calhoun, MS, SelfMade Health Network (CDC-National Disparity Network); Jennifer Redmond Knight, DrPH, University of Kentucky College of Public Health (SelfMade Health Network-Regional Resource Lead Organization)
  3. Innovative Partnerships and Strategies to Promote Cancer Genomics: Best Practices in Michigan’s Comprehensive Cancer Control Plan
    Debra A. Duquette, MS, Michigan Department of Health and Human Services; Polly Hager, Michigan Department of Community Health
  4. Evolution in Motion: How Michigan Developed a Breast and Cervical Cancer Navigation Program Model in Response to the Affordable Care Act
    Debbie Webster, BSN, MSW, Michigan Department of Health and Human Services; Bethany Hollender, MPH, MSW, Michigan Department of Health and Human Services

 Top of Page

Prevention/Programmatic

Leading with Tradition: Facing Cancer in Tribal Communities

Session Moderator: Donald Haverkamp, MPH, CDC

Chronic diseases, including cancer, have affected American Indian/Alaska Native communities disproportionally. This session will highlight public health efforts by tribal communities to address cancer’s impact.

  1. Advancing Health Equity in American Indian Communities: An Approach to Culturally Appropriate Prevention
    Melanie L. Plucinski, MPH, American Indian Cancer Foundation; Amber Cardinal, MPH, American Indian Cancer Foundation; Christopher Johnson, MA, American Indian Cancer Foundation
  2. Health Disparities, Cancer, among the Haudenosaunee (People of the Longhouse)
    Dean S. Seneca, MPH, MCURP, CDC; Rodney C. Haring, PhD, MSW, Roswell Park Cancer Institute; Melissa A. Jim, MPH, CDC
  3. Cancer Screening in Indian Country: An Overview of What Works in Tribal Communities
    Breannon E. Babbel, The National Indian Health Board
  4. The Importance of Native Patient Navigators for Increasing Colorectal Cancer Screening Rates in American Indian Communities
    Tinka Duran, BS, CPH, Great Plains Tribal Chairmen’s Health Board; Stella S. Zimmerman, ACET

 Top of Page

Prevention/Research

Partnering for Prevention: The Cancer Prevention and Control Research Network’s Collaborations with Federally Qualified Health Centers

Session Moderator: Karen Glanz, PhD, MPH, University of Pennsylvania

The Cancer Prevention and Control Research Network (CPCRN) is a national network of academic, community-engaged researchers working to accelerate the adoption of evidence-based cancer prevention and control in communities through effective dissemination and implementation strategies, including among federally qualified health centers. This session discusses the outcomes of this partnership to reduce health disparities in disadvantaged populations.

  1. Federally Qualified Health Centers As a Key Partner in Community-Clinical Linkages to Support HPV Vaccination
    Robin Vanderpool, DrPH, University of Kentucky; Heather M. Brandt, PhD, University of South Carolina Arnold School of Public Health; Laura Seegmiller, MPH, University of Iowa; Lindsay Stradtman, University of Kentucky College; Jason Daniel-Ulloa, PhD, MPH, University of Iowa; Thuy Vu, MPH, University of Washington; Vicky Taylor, MD, Fred Hutchinson Cancer Research Center; Paige Farris, MSW, Oregon Health and Science University; Susan J. Curry, PhD, University of Iowa
  2. Implementation of Lung Cancer Screening Among Federally Qualified Health Centers (FQHCs) in the U.S.
    Susan A. Flocke, PhD, Case Western Reserve University; Robin Vanderpool, DrPH, University of Kentucky; Jan Eberth, University of South Carolina; Richard Hoffman, MD, University of Iowa; Daniel Reuland, MD, MPH, University of North Carolina School of Medicine; Genevieve Birkby, PhD, Case Western Reserve University; Steven Zeliadt, PhD, University of Washington
  3. Partnering for Prevention: The Cancer Prevention and Control Research Network’s Collaborations with Federally Qualified Health Centers
    Catherine Lois Rohweder, DrPH, University of North Carolina, Chapel Hill; Daniela Friedman, Arnold School of Public Health; Jennifer Leeman, DrPH, MDiv, University of North Carolina School of Nursing; Linda Ko, PhD, Fred Hutchinson Cancer Research Center; Karen Glanz, PhD, MPH, University of Pennsylvania

 Top of Page

TOP